Skip to main content

Juvederm FDA Approval History

Last updated by Judith Stewart, BPharm on Aug 4, 2022.

FDA Approved: Yes (First approved June 2, 2006)
Brand name: Juvederm
Generic name: dermal filler
Dosage form: Injectable Gel
Company: Allergan, Inc.
Treatment for: Facial Rejuvenation

Juvéderm hyaluronic acid dermal filler products are used for facial rejuvenation.

Development timeline for Juvederm

DateArticle
Aug  3, 2022Approval FDA Approves Juvéderm Volux XC for Improvement of Jawline Definition
Feb  8, 2022Approval FDA Approves Juvéderm Volbella XC For Undereye Hollows
Sep  3, 2019Approval FDA Approves Juvéderm Voluma XC For Mid-Face Injection Via Cannula
Mar 20, 2017Approval FDA Approves Juvéderm Vollure XC for Correction of Facial Wrinkles and Folds in Adults
Jun  1, 2016Approval FDA Approves Juvéderm Volbella XC for Use in Lips and Perioral Rhytids
Oct  1, 2015Approval FDA Approves Juvéderm Ultra XC for Lip Augmentation
Oct 23, 2013Approval FDA Approves Juvéderm Voluma XC to Correct Age-Related Volume Loss in the Cheek Area
Feb  1, 2010Approval FDA Approves Juvéderm XC Containing Lidocaine to Correct Facial Wrinkles and Folds
Jun  5, 2006Approval Juvederm Allergan, Inc. - Treatment for Facial Wrinkles and Folds

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.